Abstract

Quadruplex-forming DNA sequences are present throughout the eukaryotic genome, including in telomeric DNA. We have shown that the c-Myc promoter quadruplex-forming sequence Pu-27 selectively kills transformed cells (Sedoris, K. C., Thomas, S. D., Clarkson, C. R., Muench, D., Islam, A., Singh, R., and Miller, D. M. (2012) Genomic c-Myc quadruplex DNA selectively kills leukemia. Mol. Cancer Ther. 11, 66-76). In this study, we show that Pu-27 induces profound DNA damage, resulting in striking chromosomal abnormalities in the form of chromatid or chromosomal breaks, radial formation, and telomeric DNA loss, which induces γ-H2AX in U937 cells. Pu-27 down-regulates telomeric shelterin proteins, DNA damage response mediators (RAD17 and RAD50), double-stranded break repair molecule 53BP1, G2 checkpoint regulators (CHK1 and CHK2), and anti-apoptosis gene survivin. Interestingly, there are no changes of DNA repair molecules H2AX, BRCA1, and the telomere maintenance gene, hTERT. ΔB-U937, where U937 cells stably transfected with deleted basic domain of TRF2 is partially sensitive to Pu-27 but exhibits no changes in expression of shelterin proteins. However, there is an up-regulation of CHK1, CHK2, H2AX, BRCA1, and survivin. Telomere dysfunction-induced foci assay revealed co-association of TRF1with γ-H2AX in ATM deficient cells, which are differentially sensitive to Pu-27 than ATM proficient cells. Alt (alternating lengthening of telomere) cells are relatively resistant to Pu-27, but there are no significant changes of telomerase activity in both Alt and non-Alt cells. Lastly, we show that this Pu-27-mediated sensitivity is p53-independent. The data therefore support two conclusions. First, Pu-27 induces DNA damage within both telomeric and nontelomeric regions of the genome. Second, Pu-27-mediated telomeric damage is due, at least in part, to compromise of the telomeric shelterin protein complex.

Highlights

  • G-quadruplex forming DNA of gene promoter associated with cell death and growth arrest

  • Cells and Cell Culture—Human histiocytic lymphoma U937 cells (ATCC) and human colon carcinoma HCT 116 p53ϩ/ϩ, HCT116 p53ϩ/Ϫ, and HCT p53Ϫ/Ϫ cells were bought from the Core Cell Center of Johns Hopkins University, ATM mouse wild type, and null (334 ATMϩ/ϩ, 4a ATMϩ/ϩ, and 695 Ϯ 743Ϫ/Ϫ) cells, and lung adenocarcinoma cell lines A549 and Sk-Lu-1 were maintained in RPMI or DMEM supplemented with 10% FCS. 5 ϫ 104 cells were plated in 6-well plates and treated with 10 ␮M of Pu-27 or control cytosine-rich oligonucleotide (CRO) day

  • There were no changes of DNA repair molecules (H2AX and BRCA1) and telomere maintenance gene telomerase reverse transcriptase (Fig. 6A) in U937 cells. ⌬B-U937 cells, comparing to U937 cells presented no changes of telomeric shelterin proteins (TRF2, TRF1, POT1, and TIN2), DNA damage response mediators (RAD17 and RAD50) and double-stranded breaks (DSBs) repair factor 53BP1; down-regulation of upstream kinase ATM; upregulation of G2 checkpoint molecules (CHK1 and CHK2); and DNA repair molecules (H2AX and BRCA1) (Fig. 6B)

Read more

Summary

Background

G-quadruplex forming DNA of gene promoter associated with cell death and growth arrest. Results: G-quadruplex forming DNA at c-Myc promoter Pu27 destabilizes proteins at telomere and inhibits DNA repair molecules. Quadruplex-forming DNA sequences are present throughout the eukaryotic genome, including in telomeric DNA. We have shown that the c-Myc promoter quadruplex-forming sequence Pu-27 selectively kills transformed cells Pu-27 down-regulates telomeric shelterin proteins, DNA damage response mediators (RAD17 and RAD50), double-stranded break repair molecule 53BP1, G2 checkpoint regulators (CHK1 and CHK2), and anti-apoptosis gene survivin. A substantial proportion (ϳ80%) of c-Myc expression is regulated by the nuclease hypersensitivity element III1 element, of which Pu-27 is a critical part An oligonucleotide encoding this sequence, Pu-27, has been shown to inhibit the proliferation of tumor cells derived from different tissues including breast, lung, and blood. The TRF2 N-terminal domain, which includes the basic domain of TRF2, condenses the telomeric end by

The abbreviations used are
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call